Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2019 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Addressing Healthcare Worker and Patient Safety Issues
By Patrick M. Schmidt
Features
Addressing Workplace Violence in Healthcare Facilities
By
Abbie Cornett
ADHD in Reproductive-Age Women
By
Diane L.M. Cook
Infectious Mononucleosis: The Best-Recognized Epstein-Barr Virus Infection
By
BSTQ Staff
Improving Access to Clinical Trial Data
By
Amy Scanlin, MS
Making Sense of the Suicide Epidemic
By
Trudie Mitschang
BioTrends Watch
Washington Report
FDA Takes Steps for the Development of Non-Opioid Pain Medications
$293 Million Awarded by HHS to Expand Primary Healthcare Workforce
CMS’s New Oncology Care Model Aims to Provide Better Care for Chemotherapy Patients
CMS to Strengthen and Enhance Oversight and Transparency of Medicare Accrediting Organizations
Reimbursement FAQs
Approaching New Payment Rules
Healthcare Management
Adopting a Social Media Strategy
Industry News
Accelerated Dosing Regimen Approved for Japanese Encephalitis Vaccine
First Therapy Approved to Treat Rare Blood Clotting Disorder
FDA Approves Hepatitis A and Measles Exposure Drug
Majority of Vaccination Bills Propose Increasing Exemptions, But Most Enacted Limit Exemptions
Study Finds Nasal Flu Vaccine Less Effective Than the Flu Shot
Romiplostim Approved to Treat Pediatric Patients with Immune Thrombocytopenia
Human Vaccines Project Launches Study of How the Immune System Responds to the Flu
FDA Approves Drug to Treat Acute Myeloid Leukemia
Study Says Glaucoma May Be an Autoimmune Disease
Tdap Booster Vaccine Receives Expanded FDA Indication
Common Misconceptions Are the Cause for Almost Half of U.S. Adults Skipping the Flu Shot
Severe Flu Increases Risks for Pregnant Women and Their Babies
BioFocus
Industry Insight
Human Albumin as Drug Therapy for Decompensated Cirrhosis: A New Lifesaving Role for an Old Player?
By Keith Berman, MPH, MBA
Patient Profile
Male Breast Cancer: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Male Breast Cancer: A Scientist's Perspective
By Trudie Mitschang
BioSources
BioResearch
Subcutaneous Lanadelumab Treatment Reduces Attack Rate in Patients with Hereditary Angioedema
IVIG Therapy Reduces In-Hospital Mortality and Ventricular Function Loss in Patients with Acute Myocarditis: Meta-Analysis